During our cutoff testing of reimbursement grants, we noted that the Company's internal controls,did not effectively ensure proper period-end recognition. Specifically, certain grant transactions incurred in 2022 and 2023 were incorrectly recorded in the subsequent fiscal years (2023 and 2024, respectively).